{"id":"placebo-isotonic-saline-serum","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions (if administered parenterally)"},{"rate":null,"effect":"Fluid overload (with excessive volume)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Isotonic saline (0.9% sodium chloride) is an inert solution that matches the osmotic pressure of blood and body fluids, making it suitable for intravenous or topical administration without causing cellular damage. As a placebo, it provides a chemically and osmotically neutral comparator in clinical trials. It has no intended therapeutic mechanism beyond maintaining fluid balance and serving as a delivery vehicle.","oneSentence":"Isotonic saline serum serves as a physiologically balanced control or vehicle with no active pharmacological mechanism.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:07.948Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Placebo control in clinical trials"}]},"trialDetails":[{"nctId":"NCT05652504","phase":"PHASE1","title":"Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)","status":"SUSPENDED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-04-01","conditions":"Malaria","enrollment":400},{"nctId":"NCT03844061","phase":"PHASE2","title":"Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis","status":"RECRUITING","sponsor":"Hospital for Special Surgery, New York","startDate":"2019-07-29","conditions":"Systemic Sclerosis","enrollment":30},{"nctId":"NCT04751175","phase":"PHASE4","title":"Management of Pain in Lumbar Arthrodesis","status":"COMPLETED","sponsor":"Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta","startDate":"2013-07-04","conditions":"Pain, Postoperative","enrollment":128},{"nctId":"NCT04641351","phase":"PHASE4","title":"Corticosteroid Meniscectomy Randomized Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2021-05-27","conditions":"Osteoarthritis, Knee, Meniscus Tear, Meniscus; Degeneration","enrollment":150},{"nctId":"NCT03418038","phase":"PHASE2","title":"Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2018-03-23","conditions":"Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent Diffuse Large B-Cell Lymphoma","enrollment":80},{"nctId":"NCT06599307","phase":"PHASE2","title":"The Effect of Rituximab on Cognitive and Hand Functions in Secondary Progressive Multiple Sclerosis","status":"RECRUITING","sponsor":"Cairo University","startDate":"2024-08-01","conditions":"Secondary Progressive Multiple Sclerosis (SPMS)","enrollment":46},{"nctId":"NCT05701189","phase":"PHASE2","title":"Evaluating Efgartigimod in Patients With Guillain-Barré Syndrome","status":"WITHDRAWN","sponsor":"Chafic Karam","startDate":"2024-09-10","conditions":"Guillain-Barre Syndrome","enrollment":""},{"nctId":"NCT04862221","phase":"PHASE2","title":"TReatment for ImmUne Mediated PathopHysiology","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2022-02-09","conditions":"Acute Liver Failure, Fulminant Hepatic Failure, Hepatic Encephalopathy","enrollment":163},{"nctId":"NCT05116189","phase":"PHASE3","title":"Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-12-13","conditions":"Ovarian Cancer, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms","enrollment":643},{"nctId":"NCT03847428","phase":"PHASE3","title":"Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2019-04-29","conditions":"Hepatocellular Carcinoma","enrollment":908},{"nctId":"NCT05350774","phase":"PHASE2","title":"Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2","status":"ENROLLING_BY_INVITATION","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2023-07-10","conditions":"Systemic Inflammation, Neuroinflammation, Microvascular Thrombosis","enrollment":45},{"nctId":"NCT04608630","phase":"PHASE2","title":"Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults","status":"RECRUITING","sponsor":"Australian and New Zealand Intensive Care Research Centre","startDate":"2021-07-15","conditions":"Critical Illness, Osteoporosis","enrollment":450},{"nctId":"NCT07246863","phase":"PHASE2","title":"Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC","status":"RECRUITING","sponsor":"CatalYm GmbH","startDate":"2025-10-07","conditions":"Metastatic Non-Squamous Non-Small Cell Lung Cancer, Adult Solid Tumor","enrollment":131},{"nctId":"NCT05832034","phase":"PHASE2, PHASE3","title":"Add-on Intravenous Immunoglobulins in Early Myositis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2021-09-13","conditions":"Inflammatory Myopathy, Idiopathic, Dermatomyositis, Antisynthetase Syndrome","enrollment":44},{"nctId":"NCT06797375","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy Participants","status":"COMPLETED","sponsor":"Rallybio","startDate":"2025-04-14","conditions":"Hematologic Diseases, Autoimmune Diseases","enrollment":16},{"nctId":"NCT04066348","phase":"PHASE2","title":"TNF-α Treatment of Blast-Induced Tinnitus","status":"RECRUITING","sponsor":"Wayne State University","startDate":"2022-07-01","conditions":"Tinnitus, Noise Induced","enrollment":88},{"nctId":"NCT06305780","phase":"PHASE2","title":"RECOVER-AUTONOMIC Platform Protocol","status":"COMPLETED","sponsor":"Kanecia Obie Zimmerman","startDate":"2024-03-11","conditions":"Long COVID, Long Covid19, Long Covid-19","enrollment":381},{"nctId":"NCT03929601","phase":"PHASE2","title":"Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2023-10-30","conditions":"Type 1 Diabetes Mellitus","enrollment":74},{"nctId":"NCT04380740","phase":"PHASE2","title":"Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis","status":"RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2022-03-30","conditions":"Graft Vs Host Disease","enrollment":160},{"nctId":"NCT07059091","phase":"PHASE2","title":"Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-02-12","conditions":"Chronic Obstructive Pulmonary Disease (COPD), Allergies","enrollment":334},{"nctId":"NCT07415655","phase":"PHASE2","title":"Modulation of Cerebral Ischemia by Albumin","status":"NOT_YET_RECRUITING","sponsor":"University Hospital Hradec Kralove","startDate":"2026-02-03","conditions":"Ischemic Stroke","enrollment":100},{"nctId":"NCT02743455","phase":"PHASE1","title":"A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-07-05","conditions":"Yellow Fever, Yellow Fever Immunisation","enrollment":92},{"nctId":"NCT03635567","phase":"PHASE3","title":"Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2018-10-25","conditions":"Cervical Cancer","enrollment":617},{"nctId":"NCT05056220","phase":"PHASE3","title":"Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites","status":"RECRUITING","sponsor":"Aleksander Krag","startDate":"2024-02-26","conditions":"Decompensated Cirrhosis and Ascites","enrollment":240},{"nctId":"NCT03153319","phase":"PHASE1, PHASE2","title":"Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI","status":"ACTIVE_NOT_RECRUITING","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2017-06-05","conditions":"Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis VI","enrollment":14},{"nctId":"NCT03778957","phase":"PHASE3","title":"A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2018-11-30","conditions":"Hepatocellular Carcinoma","enrollment":724},{"nctId":"NCT02990286","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of Rituximab With Mycophenolate Mofetil in Patients With Interstitial Lung Diseases","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2017-01-20","conditions":"Lung Disease, Interstitial","enrollment":122},{"nctId":"NCT01757418","phase":"PHASE1, PHASE2","title":"Intravenous Gammaglobulin for Sickle Cell Pain Crises","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2008-11","conditions":"Sickle Cell Disease, Pain","enrollment":300},{"nctId":"NCT03362242","phase":"PHASE1","title":"Study of ARO-AAT in Normal Adult Volunteers","status":"COMPLETED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2018-03-12","conditions":"Alpha 1-Antitrypsin Deficiency","enrollment":45},{"nctId":"NCT05645107","phase":"PHASE3","title":"A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma","status":"RECRUITING","sponsor":"Grifols Therapeutics LLC","startDate":"2022-12-26","conditions":"Hypogammaglobulinemia, Bacterial Infections, B-cell Chronic Lymphocytic Leukemia","enrollment":386},{"nctId":"NCT07271771","phase":"PHASE4","title":"The Effect of Denosumab on Muscle and Strength and Insulin Sensitivity","status":"RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2024-05-21","conditions":"Osteoporosis","enrollment":40},{"nctId":"NCT06527235","phase":"PHASE3","title":"Meniscal INfiltration of Corticosteroid Guided With Ultra Sonography","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2025-03-06","conditions":"Meniscus Lesion","enrollment":152},{"nctId":"NCT07073846","phase":"PHASE4","title":"Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery.","status":"RECRUITING","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2025-10-06","conditions":"Morbid Obesity Requiring Bariatric Surgery, Postoperative Pain, Postoperative Pain Management","enrollment":104},{"nctId":"NCT07252505","phase":"EARLY_PHASE1","title":"Early Intravenous Magnesium Sulfate and Its Impact on Cerebral Vasospasm in Traumatic Subarachnoid Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-11","conditions":"Trauma and Emergency Care","enrollment":50},{"nctId":"NCT06455319","phase":"PHASE2","title":"Precision Administration of Anti-thymocyte Globulin With or Without Verapamil","status":"RECRUITING","sponsor":"University of Florida","startDate":"2025-11-12","conditions":"Type 1 Diabetes","enrollment":60},{"nctId":"NCT05730816","phase":"PHASE2","title":"MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2023-04-04","conditions":"Mesothelioma","enrollment":130},{"nctId":"NCT03740165","phase":"PHASE3","title":"Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2018-12-18","conditions":"Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms","enrollment":1367},{"nctId":"NCT07219459","phase":"PHASE2","title":"Visugromab, Nivolumab and a Tyrosine Kinase Inhibitor (TKI) Compared to Double Placebo and a TKI in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure","status":"NOT_YET_RECRUITING","sponsor":"CatalYm GmbH","startDate":"2026-02","conditions":"Unresectable or Metastatic Hepatocellular Carcinoma, Failure of First-Line Treatment That Included an Anti PD-(L)1 Compound, Child-Pugh A Hepatocellular Carcinoma","enrollment":104},{"nctId":"NCT02367040","phase":"PHASE3","title":"Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)","status":"COMPLETED","sponsor":"Bayer","startDate":"2015-08-03","conditions":"Lymphoma,Non-Hodgkin","enrollment":458},{"nctId":"NCT03620136","phase":"PHASE3","title":"Comparison of Two Techniques of Locoregional Analgesia in Total Knee Prosthesis Surgery : Block to the Adductor Channel Versus Peri-articular Local Infiltrations","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2018-02-07","conditions":"Analgesic","enrollment":98},{"nctId":"NCT04291703","phase":"PHASE2","title":"STOP-T1D Low-Dose (ATG)","status":"TERMINATED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2023-11-01","conditions":"Diabetes Mellitus, Type 1","enrollment":2},{"nctId":"NCT04869397","phase":"PHASE2","title":"Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal Cells","status":"TERMINATED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2021-06-14","conditions":"Covid19","enrollment":19},{"nctId":"NCT06934473","phase":"NA","title":"Effects of Endogenous GIP on Postprandial Blood Pressure in Healthy Individuals","status":"RECRUITING","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2025-05-21","conditions":"Bloodpressure","enrollment":16},{"nctId":"NCT04824092","phase":"PHASE3","title":"Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Incyte Corporation","startDate":"2021-05-11","conditions":"Diffuse Large B-cell Lymphoma","enrollment":899},{"nctId":"NCT07125664","phase":"PHASE2","title":"Intravenous Alpha-1 Antitrypsin for Hospitalized Patients With COPD Exacerbations (AECOPD Study)","status":"NOT_YET_RECRUITING","sponsor":"Fondazione IRCCS Policlinico San Matteo di Pavia","startDate":"2025-10-01","conditions":"Acute Exacerbation Chronic Obstructive Pulmonary Disease","enrollment":36},{"nctId":"NCT06675500","phase":"PHASE3","title":"Evaluation of the Role of Magnesium in Prevention of AF Post Cardiac Surgery","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-11-01","conditions":"Atrial Fibrillation (AF), Magnesium Sulfate, Post Cardiac Surgery Patients","enrollment":130},{"nctId":"NCT02580604","phase":"NA","title":"PTH And Calcium Responses to Exercise in Older Adults Experiment 2 (PACE Sr. 2)","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2015-11","conditions":"Osteoporosis","enrollment":12},{"nctId":"NCT05856331","phase":"PHASE2","title":"Study of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema","status":"COMPLETED","sponsor":"Sanofi","startDate":"2023-10-12","conditions":"Alpha 1-Antitrypsin Deficiency, Emphysema","enrollment":99},{"nctId":"NCT06524960","phase":"PHASE1, PHASE2","title":"Denosumab for Type 1 Diabetes","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2024-09-03","conditions":"Type 1 Diabetes","enrollment":45},{"nctId":"NCT04368806","phase":"PHASE2, PHASE3","title":"A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis","status":"RECRUITING","sponsor":"Nature Cell Co. Ltd.","startDate":"2021-05-26","conditions":"Osteoarthritis, Knee","enrollment":140},{"nctId":"NCT06305793","phase":"PHASE2","title":"RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kanecia Obie Zimmerman","startDate":"2024-03-11","conditions":"Long COVID, Long Coronavirus Disease 2019 (Covid19), Long Covid-19","enrollment":200},{"nctId":"NCT07056478","phase":"PHASE3","title":"RANKL Inhibition to Combat Sarcopenia in Hip Fracture Patients","status":"NOT_YET_RECRUITING","sponsor":"Prince of Wales Hospital, Shatin, Hong Kong","startDate":"2026-01-01","conditions":"Sarcopenia in Elderly","enrollment":130},{"nctId":"NCT00463580","phase":"PHASE4","title":"A Study of Infliximab for Treatment Resistant Major Depression","status":"COMPLETED","sponsor":"Emory University","startDate":"2008-12","conditions":"Depression","enrollment":60},{"nctId":"NCT06136546","phase":"PHASE2","title":"Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-01-23","conditions":"Depressive Disorder, Major, Inflammation","enrollment":100},{"nctId":"NCT06064877","phase":"PHASE3","title":"A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma","status":"RECRUITING","sponsor":"AVEO Pharmaceuticals, Inc.","startDate":"2024-01-11","conditions":"Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma","enrollment":410},{"nctId":"NCT01785420","phase":"PHASE3","title":"Pre Operative Trastuzumab in Operable Breast Cancer","status":"RECRUITING","sponsor":"Dr Rajendra A. Badwe","startDate":"2013-05","conditions":"Carcinoma Breast Stage I, HER2 Positive Breast Cancer","enrollment":1100},{"nctId":"NCT04232657","phase":"PHASE2","title":"Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2021-03-01","conditions":"Spinal Cord Injury (=3 Years), Sublesional Bone Loss Secondary to SCI","enrollment":36},{"nctId":"NCT03194815","phase":"PHASE2","title":"IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2","status":"RECRUITING","sponsor":"University of Cambridge","startDate":"2017-11-01","conditions":"Psychosis, Autoimmune Encephalitis","enrollment":70},{"nctId":"NCT06892951","phase":"PHASE1, PHASE2","title":"CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Tours","startDate":"2025-06","conditions":"Pneumocystis Pneumonia, Pneumocystis Jirovecii Infection, Pneumocystis Infections","enrollment":100},{"nctId":"NCT04990232","phase":"PHASE2","title":"Personalized Immunotherapy in Sepsis","status":"COMPLETED","sponsor":"Hellenic Institute for the Study of Sepsis","startDate":"2021-07-29","conditions":"Sepsis","enrollment":280},{"nctId":"NCT06208904","phase":"NA","title":"The Involvement of the Gut Hormone GIP in the Pathophysiology of Post Prandial Hypotension","status":"ENROLLING_BY_INVITATION","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2024-05-15","conditions":"PostPrandial Hypotension","enrollment":18},{"nctId":"NCT05145283","phase":"PHASE2","title":"Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-03-16","conditions":"Acute Ischemic Stroke, Acute Renal Injury","enrollment":250},{"nctId":"NCT03941132","phase":"PHASE2, PHASE3","title":"Clinical Phase II/III Trial of Ustekinumab to Treat Type 1 Diabetes (UST1D2)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of British Columbia","startDate":"2021-01-04","conditions":"Type 1 Diabetes Mellitus","enrollment":66},{"nctId":"NCT03312907","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2018-03-01","conditions":"Systemic Lupus Erythematosus","enrollment":292},{"nctId":"NCT06052176","phase":"PHASE2","title":"Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement","status":"RECRUITING","sponsor":"Hunter Holmes Mcguire Veteran Affairs Medical Center","startDate":"2023-11-02","conditions":"Cirrhosis, Hepatic Encephalopathy","enrollment":30},{"nctId":"NCT03737643","phase":"PHASE3","title":"Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2019-01-04","conditions":"Advanced Ovarian Cancer","enrollment":1407},{"nctId":"NCT05299242","phase":"PHASE2, PHASE3","title":"The Anti-Freaze-F Study- \"Anti-TNF for Treatment of Frozen Shoulder - a Feasibility Study\"","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2022-07-21","conditions":"Frozen Shoulder","enrollment":9},{"nctId":"NCT05300035","phase":"PHASE2","title":"Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control","status":"RECRUITING","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2024-04-11","conditions":"HIV/AIDS and Infections","enrollment":69},{"nctId":"NCT05622201","phase":"PHASE2","title":"A Randomized Controlled Trial With Rituximab for Psychotic Disorder in Adults","status":"RECRUITING","sponsor":"Region Örebro County","startDate":"2023-03-21","conditions":"Schizophrenia Spectrum and Other Psychotic Disorders","enrollment":120},{"nctId":"NCT05605639","phase":"PHASE4","title":"Phrenic Nerve Infiltration in Neck Pain","status":"RECRUITING","sponsor":"University of Seville","startDate":"2022-11-17","conditions":"Chronic Neck Pain","enrollment":60},{"nctId":"NCT02626455","phase":"PHASE3","title":"Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)","status":"TERMINATED","sponsor":"Bayer","startDate":"2016-01-06","conditions":"Lymphoma, Non-Hodgkin","enrollment":551},{"nctId":"NCT05604521","phase":"PHASE1","title":"A Phase 1 Trial of PfSPZ Vaccine in Healthy Adults to Determine Safety, Tolerability and Efficacy Against Heterologous CHMI","status":"TERMINATED","sponsor":"Sanaria Inc.","startDate":"2022-12-06","conditions":"Malaria, Malaria,Falciparum","enrollment":31},{"nctId":"NCT06062875","phase":"PHASE2","title":"Effects of TNF Blockade on Human BPH/LUTS","status":"RECRUITING","sponsor":"Endeavor Health","startDate":"2024-01-24","conditions":"Benign Prostatic Hyperplasia (BPH)","enrollment":70},{"nctId":"NCT06643780","phase":"PHASE4","title":"RANK-ligand Inhibition to Combat Sarcopenia with Underlying Osteoporosis","status":"RECRUITING","sponsor":"Prince of Wales Hospital, Shatin, Hong Kong","startDate":"2024-04-09","conditions":"Sarcopenia in Elderly","enrollment":120},{"nctId":"NCT04584749","phase":"PHASE4","title":"Lidocaine as an Anesthetic Adjuvant in Liver and Gastric Laparoscopic Surgery","status":"COMPLETED","sponsor":"Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta","startDate":"2020-11-16","conditions":"Pain, Postoperative","enrollment":96},{"nctId":"NCT02753283","phase":"PHASE4","title":"Preventing Osteoporosis Using Denosumab","status":"COMPLETED","sponsor":"Susan L. Greenspan","startDate":"2016-06","conditions":"Osteoporosis, Postmenopausal, Osteoporosis, Osteoporotic Fractures","enrollment":201},{"nctId":"NCT04852172","phase":"PHASE1, PHASE2","title":"L-citrulline Injection in Patients Aged 6-21 Years Old with Sickle Cell Disease Presenting with Vaso-Occlusive Crisis (VOC)","status":"TERMINATED","sponsor":"Asklepion Pharmaceuticals, LLC","startDate":"2021-04-29","conditions":"Acute Vaso Occlusive Crisis (VOC)","enrollment":30},{"nctId":"NCT02673931","phase":"NA","title":"GLP-1 and Hyperoxia for Organ Protection in Heart Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2016-02","conditions":"Coronary Disease, Shock, Cardiogenic, Renal Failure","enrollment":1400},{"nctId":"NCT06154707","phase":"PHASE3","title":"Clinical Controlled Study on the Efficacy of Denosumab in Treating Osteoporosis in the Domestic Population and Its Impact on Sarcopenia-related Outcomes","status":"UNKNOWN","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2024-02-01","conditions":"Sarcopenia, Osteoporosis, Denosumab","enrollment":86},{"nctId":"NCT06549231","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of Rituximab and Mycophenolate Mofetil Combination in Patients With Interstitial Lung Disease Related to Systemic Sclerosis","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Tours","startDate":"2024-11-15","conditions":"Interstitial Lung Disease With Systemic Sclerosis","enrollment":102},{"nctId":"NCT04547348","phase":"PHASE3","title":"The DENOCHARCOT Trial","status":"RECRUITING","sponsor":"Ole Lander Svendsen","startDate":"2020-11-01","conditions":"Charcot Foot, Diabetes Mellitus","enrollment":38},{"nctId":"NCT06534450","phase":"PHASE3","title":"The Effects Of Therapeutic Plasma Exchange (TPE) On Age Related Biomarkers And Epigenetics","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dobri Kiprov","startDate":"2022-09-12","conditions":"Aging","enrollment":40},{"nctId":"NCT05596786","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of Rituximab in Patients With Progressive Interstitial Lung Disease (ILD) With Inflammatory Component: a Multicentre Double-blind Placebo-controlled Randomized Trial","status":"RECRUITING","sponsor":"University Hospital, Tours","startDate":"2023-01-16","conditions":"Lung Diseases","enrollment":126},{"nctId":"NCT06291363","phase":"PHASE4","title":"Impact of Administration of Esmolol on Nociception Level-guided Control of Nociception.","status":"RECRUITING","sponsor":"Ciusss de L'Est de l'Île de Montréal","startDate":"2024-04-16","conditions":"Opioid Use, Unspecified, Anesthesia, Nociceptive Pain","enrollment":64},{"nctId":"NCT06491043","phase":"PHASE2","title":"Treatment of Chronic Obstructive Pulmonary Disease by Infusion of Allogenic Mesenchymal Stem Cells","status":"RECRUITING","sponsor":"Meribank Biotech Co., Ltd.","startDate":"2024-06-11","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":90},{"nctId":"NCT03180957","phase":"PHASE2","title":"Repurposing Anti-TNF for Treating Dupuytren's Disease","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2016-03-02","conditions":"Dupuytren's Disease","enrollment":140},{"nctId":"NCT01773707","phase":"PHASE2","title":"CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2013-03","conditions":"Abnormal Glucose Tolerance, Type 1 Diabetes","enrollment":212},{"nctId":"NCT03010202","phase":"PHASE3","title":"The PROLONG Trial - Rituximab Maintenance Therapy in ITP","status":"UNKNOWN","sponsor":"Ostfold Hospital Trust","startDate":"2016-12","conditions":"Purpura, Thrombocytopenic, Idiopathic","enrollment":136},{"nctId":"NCT03222492","phase":"PHASE1, PHASE2","title":"Brentuximab Vedotin for Systemic Sclerosis","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2017-09-20","conditions":"Diffuse Cutaneous Systemic Sclerosis, Scleroderma, dcSSc","enrollment":17},{"nctId":"NCT05985863","phase":"PHASE1, PHASE2","title":"Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of Acute-on-Chronic Liver Failure","status":"RECRUITING","sponsor":"Beijing 302 Hospital","startDate":"2023-09-30","conditions":"Acute-On-Chronic Liver Failure","enrollment":150},{"nctId":"NCT02915263","phase":"PHASE2","title":"The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes","status":"TERMINATED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2017-09-11","conditions":"Diabetes Complications, Diabetes Mellitus, Diabetic Neuropathies","enrollment":13},{"nctId":"NCT05823532","phase":"PHASE4","title":"Anti-Inflammatory Challenge in Schizophrenia","status":"RECRUITING","sponsor":"Emory University","startDate":"2024-04-18","conditions":"Schizophrenia","enrollment":20},{"nctId":"NCT06366412","phase":"PHASE4","title":"Dexmedetomidine on Postoperative Cognitive Dysfunction and Serum Tau-217 Protein.","status":"RECRUITING","sponsor":"Minia University Hospital","startDate":"2024-04","conditions":"Cognitive Impairment","enrollment":94},{"nctId":"NCT03029442","phase":"PHASE4","title":"The Efficacy of Denosumab in Incomplete Patients Spinal Cord Injury","status":"TERMINATED","sponsor":"James J. Peters Veterans Affairs Medical Center","startDate":"2017-04-01","conditions":"Secondary Osteoporosis, Spinal Cord Injury","enrollment":5},{"nctId":"NCT00448253","phase":"PHASE1","title":"Safety and Pharmacokinetic Study of Anthrax Immune Globulin Derived From Human Serum","status":"COMPLETED","sponsor":"Emergent BioSolutions","startDate":"2007-07","conditions":"Symptoms of Inhalational Anthrax","enrollment":92},{"nctId":"NCT03093064","phase":"PHASE1","title":"Inflammatory Response In Schizophrenia","status":"COMPLETED","sponsor":"King's College London","startDate":"2017-04-01","conditions":"Schizophrenia","enrollment":66},{"nctId":"NCT05325580","phase":"PHASE3","title":"Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department","status":"RECRUITING","sponsor":"University of Monastir","startDate":"2021-12-01","conditions":"Head Pain","enrollment":424},{"nctId":"NCT05792774","phase":"PHASE4","title":"Phrenic Nerve Infiltration in Fibromyalgia","status":"COMPLETED","sponsor":"University of Seville","startDate":"2023-04-03","conditions":"Fibromyalgia","enrollment":60},{"nctId":"NCT04747795","phase":"PHASE3","title":"Early Administration of Vitamin C in Patients With Sepsis or Septic Shock in Emergency Departments","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2021-06-01","conditions":"Sepsis, Septic Shock, Sepsis, Severe","enrollment":301},{"nctId":"NCT06183008","phase":"PHASE4","title":"IVIG in Painful Sensory Neuropathy","status":"NOT_YET_RECRUITING","sponsor":"Sorlandet Hospital HF","startDate":"2024-02","conditions":"Sensory Neuropathy, Small Fiber Neuropathy","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"placebo - isotonic saline serum","genericName":"placebo - isotonic saline serum","companyName":"CHU de Reims","companyId":"chu-de-reims","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Isotonic saline serum serves as a physiologically balanced control or vehicle with no active pharmacological mechanism. Used for Placebo control in clinical trials.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}